Abstract: The present invention provides methods of alleviating one or more signs or symptoms of smooth muscle diseases. Com-positions of the disclosure may include a plasmid vector containing a nucleic acid that encodes a Maxi-K channel peptide. Compositions of the disclosure may be administered intradetrusorally to at least two or more sites at a single unit dose.
Type:
Application
Filed:
January 3, 2023
Publication date:
September 21, 2023
Applicant:
ION CHANNEL INNOVATIONS, LLC
Inventors:
Arnold MELMAN, George CHRIST, Karl-Erik ANDERSSON
Abstract: The present invention provides methods of alleviating one or more signs or symptoms of smooth muscle diseases. Compositions of the disclosure may include a plasmid vector containing a nucleic acid that encodes a Maxi-K channel peptide. Compositions of the disclosure may be administered intradetrusorally to at least two or more sites at a single unit dose.
Type:
Application
Filed:
May 14, 2018
Publication date:
September 3, 2020
Applicant:
ION CHANNEL INNOVATIONS, LLC
Inventors:
Arnold MELMAN, George CHRIST, Karl-Erik ANDERSSON